BRIEF published on 08/07/2024 at 22:06, 1 year 3 months ago Amdocs Reports Record Third Quarter Revenue for Fiscal 2024 Revenue Growth Record Revenue Cloud Solutions Managed Services Profitability Targets
PRESS RELEASE published on 08/07/2024 at 22:01, 1 year 3 months ago Amdocs Limited Reports Third Quarter Fiscal 2024 Results Amdocs Limited reports record quarterly revenue of $1.25 billion, up 1.1% YoY, with expectations for continued growth. Achieved solid Q3 results and accelerated profitability gains Record Revenue Amdocs Limited Cloud Solutions Profitability Gains Fiscal 2024 Outlook
BRIEF published on 08/06/2024 at 13:05, 1 year 3 months ago Amdocs Releases Fourth Quarter Fiscal 2024 Investor Conference Schedule Amdocs Investor Relations Fiscal 2024 Investor Conferences Software And Services
PRESS RELEASE published on 08/06/2024 at 13:00, 1 year 3 months ago Amdocs Releases Fourth Quarter Fiscal 2024 Investor Conference Schedule Amdocs announces participation in upcoming investor conferences during Q4 fiscal 2024. Prominent executives to present and meet investors Amdocs Fiscal 2024 Investor Conferences Communications Executives
Published on 12/05/2025 at 02:35, 3 hours 20 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 55 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 50 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 55 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 25 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 4 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 30 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 40 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 45 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 55 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 10 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 11 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 54 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
